Scientists find clues on why COVID vaccine causes chronic health problems in some
For a majority of people, the COVID vaccine doesn't cause adverse health effects — but a small percentage experience chronic symptoms that can last for months or even years.
Yale researchers recently made some discoveries about why certain people experience this condition, which they have dubbed "post-vaccination syndrome" (PVS).
In early findings, the team recognized "potential immunological patterns" that are unique to people with PVS. The hope is that this discovery will help to enable future treatments and therapies for those who are affected.
Is Mmr Vaccine Safe For Kids? Dr. Nicole Saphier Addresses Concerns As Measles Cases Rise
"This work is still in its early stages, and we need to validate these findings," said co-senior study author Akiko Iwasaki, Sterling Professor of Immunobiology at Yale School of Medicine, in a press release.
"But this is giving us some hope that there may be something that we can use for diagnosis and treatment of PVS down the road."
Read On The Fox News App
People with this condition may suffer from excessive fatigue, exercise intolerance, brain fog, insomnia and dizziness, according to the Yale researchers.
These typically develop within a day or two of vaccination and can worsen over time.
New Bat Coronavirus Discovered In China Sparks Pandemic Concerns
"It's clear that some individuals are experiencing significant challenges after vaccination. Our responsibility as scientists and clinicians is to listen to their experiences, rigorously investigate the underlying causes, and seek ways to help," said co-senior author Harlan Krumholz, professor of cardiology at YSM, in the release.
"Post-vaccination syndrome is real, and has been found [to occur] from many vaccines, including COVID," Dr. Marc Siegel, clinical professor of medicine at NYU Langone Health and Fox News senior medical analyst, told Fox News Digital.
The researchers analyzed blood samples from 42 study participants who experienced symptoms of PVS and 22 who did not.
Those with symptoms were shown to have lower levels of two types of white blood cells. People with PVS who had never had COVID also had lower levels of antibodies against the SARS-CoV-2 spike protein, likely because they tended to have fewer vaccine doses, according to the release.
"Fewer vaccine doses and no viral infection means the body's immune system has had little opportunity to develop a defense to the virus," said the researchers.
Some of the people with PVS also had higher levels of the SARS-CoV-2 spike protein, which enables the virus to penetrate and infect host cells. This has also been linked to a higher risk of developing long COVID.
"We don't know if the level of spike protein is causing the chronic symptoms, because there were other participants with PVS who didn't have any measurable spike protein — but it could be one mechanism underlying this syndrome," said Iwasaki.
In addition to the elevated spike proteins, other factors could increase the risk of post-vaccination syndrome. Those include autoimmunity, tissue damage and reactivation of Epstein-Barr virus (EBV), the researchers wrote.
"Akiko Iwasaka is a world-renowned immunologist at Yale who has studied COVID (and COVID vaccines) extensively," Siegel pointed out.
Click Here To Sign Up For Our Health Newsletter
"In this new study, she reports that in a very small percentage of those who received COVID vaccines (and experienced prolonged side effects), there may be the presence of persistent spike protein," Siegel confirmed.
"They may also experience immune disruption, which takes the form of elevations in inflammatory immune cells (CD8 and TN alpha) and a decrease in cells that help resolve inflammation and infection (CD4 helper cells)."
The researchers agreed that more studies are essential to guide diagnosis and treatment.
"We're only just starting to make headway in understanding PVS," said Krumholz. "Every medical intervention carries some risk, and it's important to acknowledge that adverse events can occur with vaccines."
For more Health articles, visit www.foxnews.com/health
"Our focus must remain on understanding what these people are experiencing through rigorous science and addressing the needs of those affected with compassion and an open mind."
Siegel agreed, adding, "This needs to be further studied in terms of understanding how common prolonged COVID vaccine side effects are and how to predict them and treat them."Original article source: Scientists find clues on why COVID vaccine causes chronic health problems in some
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Time Magazine
31 minutes ago
- Time Magazine
Trump's First Surgeon General: RFK Jr. Purging the CDC Advisory Committee Will Put Lives at Risk
When Secretary Robert F. Kennedy Jr. began his tenure as Health and Human Services Secretary, he pledged, 'We won't take away anyone's vaccines.' However, recent policy changes under his leadership—coupled with the unprecedented dismissal of all 17 members of the CDC's Advisory Committee on Immunization Practices (ACIP) on June 9—have proven that statement false, raising grave concerns for our nation's COVID-19 response and broader vaccine policies. These shifts not only jeopardize public health but also threaten to erode trust in our health institutions at a critical time. In May 2025, the Food and Drug Administration (FDA) introduced a new COVID-19 vaccine framework, limiting access to updated vaccines for Americans aged 65 and older or those with specific risk factors. Furthermore, Secretary Kennedy announced that the Centers for Disease Control and Prevention (CDC) would no longer recommend COVID-19 vaccines for 'healthy' children or pregnant women—bypassing the standard ACIP review process. Compounding these changes, the abrupt removal of ACIP's entire panel of independent experts, who have guided evidence-based vaccine policy for decades, risks destabilizing a cornerstone of public health. These actions collectively restrict access to a vital tool for saving lives and undermine confidence in our health systems. During my tenure as Surgeon General under the first Trump administration, we faced significant public health challenges, from addressing the opioid epidemic by increasing access to Naloxone to launching Operation Warp Speed for the COVID-19 vaccine development effort. The vaccines developed under Trump's first term have proven to be one of our most effective defenses against COVID-19; yet, the current administration's new policies limit their availability, potentially leaving millions vulnerable. The dismissal of ACIP's experts—without a clear plan for replacing them with qualified scientists—further jeopardizes trust in the institutions tasked with protecting Americans. The major flaw in the new vaccine framework is its narrow assessment of risk. Although the immediate dangers of COVID-19 have lessened, it remains a leading cause of death and hospitalization, claiming nearly 50,000 lives in the U.S. in 2024—more than breast cancer or car accidents. The fact is, 75% of Americans have risk factors, such as obesity or diabetes, that increase their vulnerability to severe COVID outcomes. However, the burden is now placed on individuals to self-identify as high risk, creating confusion and inconsistency in access. Unlike other countries with centralized systems for identifying at-risk individuals, the U.S. expects patients—many of whom lack easy access to healthcare—to navigate eligibility alone. Risk assessment should also consider individual circumstances beyond underlying health conditions. A 58-year-old bus driver or healthcare worker faces significantly greater exposure than someone working remotely. By limiting vaccines to specific groups based solely on preexisting health status, the policy overlooks these critical contextual differences. Secretary Kennedy's team argues that there is insufficient evidence to support updated COVID-19 vaccines for healthy Americans under 65, but this claim is flatly unfounded. Years of real-world data demonstrate that vaccines save lives and reduce hospitalizations across all age groups. During the 2023 to 2024 fall and winter season, 95% of those hospitalized for COVID had not received an updated vaccine. While the administration cites other countries' more restrictive vaccine policies, such comparisons ignore the unique health landscape in the U.S., which includes higher obesity rates, worse maternal health outcomes, and uneven healthcare access. The policy also neglects the issue of Long COVID, which affects millions with debilitating symptoms lasting months or years. Though older adults are at higher risk for severe acute infections, Long COVID disproportionately impacts adults aged 35 to 49—and children are also affected. Vaccination reduces the risk of developing Long COVID, an essential reason many healthy individuals choose to stay up-to-date with their vaccines. Particularly concerning is the decision to end COVID vaccine recommendations for 'healthy' pregnant women, which contradicts the FDA's own guidance. Pregnant women face heightened risks of severe COVID outcomes, including death, pre-eclampsia, and miscarriage. Vaccination during pregnancy is crucial—not just for maternal health but also for protecting infants under six months, who cannot be vaccinated and rely on maternal antibodies for protection. Decades of research confirm that vaccines, including COVID vaccines, safely transfer antibodies to newborns, lowering their risk of severe illness. The dismissal of ACIP's members amplifies these concerns. ACIP has been a trusted, science-driven body that ensures vaccines are safe and effective, saving countless lives through its transparent recommendations. Its members, rigorously vetted for expertise and conflicts of interest, provide independent guidance critical to public health. Removing them without clear evidence of misconduct risks replacing qualified scientists with less experienced voices. This move fuels vaccine hesitancy and skepticism about public health decisions, particularly when paired with the bypassing of ACIP's review process for the new COVID vaccine policies. These changes create uncertainty about who can access vaccines. Without clear CDC recommendations, insurance companies may impose their own coverage criteria, potentially increasing costs for a vaccine that was previously free for most Americans. Healthcare providers, lacking federal guidance and ACIP's expertise, may struggle to advise patients, leading to a confusing and inequitable system that limits choice—hardly the 'medical freedom' Secretary Kennedy claims to champion. Ultimately, these actions threaten to erode trust in public health. FDA officials argue the new framework enhances transparency, yet bypassing ACIP's review and dismissing its members undermines that aim. Extensive data demonstrate that updated vaccines lower hospitalization and death rates, yet this evidence was sidelined. Such actions breed skepticism, making it harder to unite Americans around shared health goals. The stakes are high, but a better path is possible. Restoring trust requires transparent, evidence-based policymaking that prioritizes access to life-saving tools. I urge Secretary Kennedy and the administration to reconsider this framework, reinstate ACIP's role in vaccine policy, and ensure any new appointees are qualified, independent experts. If concerns about ACIP exist, they should be addressed through reform, not dissolution. Healthcare providers and community leaders must also educate patients about vaccination benefits, particularly for vulnerable groups like pregnant women and those with high exposure. Individuals can take action by staying informed, discussing vaccination with their doctors, and advocating for clear, equitable access to vaccines. By working together—government, providers, and citizens—we can protect lives, reduce the burden of Long COVID, and rebuild confidence in our public health system. We must seize this opportunity to unite around science and ensure a healthier, safer, and prosperous future for all Americans.
CNET
34 minutes ago
- CNET
Coolest Space Photos of 2025 Will Fill You With Cosmic Wonder
There's always something happening in space, and humanity is documenting it more quickly and clearly than ever before. Orbiting telescopes, astronauts and spacecraft are sending back a stream of photos that show off the diversity and wonder of the universe. Here are some of the best space photos of the year, so far. Los Angeles wildfires Enlarge Image ESA's Sentinel-2 satellite spotted the smoke from the Palisades Fire shortly after it started on Jan. 7. NASA Earth Observatory/Wanmei Liang/ESA/Copernicus Sentinel It wasn't just imagery of objects beyond Earth that caught our eye over the first half of the year. The European Space Agency's Sentinel-2 Earth-observing satellite documented the devastating Palisades Fire in California in January. The Jan. 7 view showed a large smoke plume stretching out over the Pacific Ocean. That was just the beginning of a series of wildfires that destroyed residences and buildings in Los Angeles County. Earth from space Enlarge Image NASA astronaut Don Pettit captured a gorgeous sunrise from the International Space Station in February. Don Pettit/NASA NASA astronaut and astrophotographer extraordinaire Don Pettit shared a knockout view of Earth from the International Space Station in late February. "Cosmic colors at sunrise; never get tired of seeing what the new day brings," he said. This photo has it all: our planet, swirling aurora lights and a sweeping vista of stars. Sunrise from the moon Enlarge Image Firefly Aerospace's Blue Ghost lander captured a triumphant view of a lunar sunrise from its landing spot on the moon. Firefly Aerospace It's tough to land successfully on the moon. Firefly Aerospace pulled off the feat in March with its Blue Ghost Mission 1. The Blue Ghost lander captured a historic view of a sunrise from the surface of the moon. The image shows the pockmarked lunar surface with the bright flash of the sun topping the horizon. Many moon missions, including Intuitive Machine's 2025 attempt, go wrong. That makes Blue Ghost's sunrise image all the more poignant. It marks a hard-earned lunar success story. Webb spots a 'cosmic tornado' Enlarge Image The James Webb Space Telescope's ability to see in near- and mid-infrared light allowed it to capture this view of Herbig-Haro 49/50. A spiral galaxy appears at its edge in the upper left. NASA, ESA, CSA, STScI The James Webb Space Telescope delivered a wild view of Herbig-Haro 49/50 in March. NASA described the space object as "a frothy-looking outflow from a nearby protostar" and a "cosmic tornado." Look for the distant spiral galaxy in the upper left. Hubble turns 35 Enlarge Image This small piece of the Rosette Nebula resembles a cloud of dark smoke passing over a lighter gauzy cloud. Gas and dust create the wild shapes seen by Hubble. NASA, ESA, STScI The venerable Hubble Space Telescope celebrated 35 years in orbit in April. NASA and ESA partied down by releasing a series of Hubble anniversary images, including views of Mars and a barred spiral galaxy. It's hard to pick just one anniversary image to highlight, but the telescope's ethereal view of the Rosette Nebula and its smoky clouds of gas and dust stands out. The nebula is a place of active star formation. Hubble's image focuses on one small, scenic part of the Rosette. Flower moon from orbit Enlarge Image That distant glow in the dark of space is the full flower moon. Earth's water and clouds are below. NASA/Nichole Ayers NASA astronaut Nichole Ayers got some full-moon photography in during May's "flower moon." Ayers had a front-row seat to the glowing lunar action from her perch on the International Space Station. Ayers shared a series of photos with Earth in the frame, emphasizing the relationship between our blue planet and our lunar neighbor. Mars rover selfie Enlarge Image A dust devil is visible in the distance to the left of the Perseverance rover. Look to the fold in the landscape for a puff of whirling dust. NASA/JPL-Caltech/MSSS NASA's Perseverance rover has been trucking around Mars since early 2021. The wheeled explorer marked its 1,500th Martian day on May 10 by taking a fresh selfie. Percy took dozens of images of itself using a camera mounted on the end of its robotic arm. NASA stitched the shots together to create the selfie. Look deeper into the image to spot a swirling dust devil dancing in the background. "Having the dust devil in the background makes it a classic," said Perseverance imaging scientist Megan Wu. "This is a great shot." The year is only half over. There are full moons, auroras, space launches and meteor showers coming down the line. Satellites are watching over Earth. Space telescopes are staring out into the cosmos and sending back postcards from our universe. Stay tuned for more stunning images.
Geek Wire
40 minutes ago
- Geek Wire
Xplore unveils colorful hyperspectral views captured by its planet-watching satellite
An image from the XCUBE-1 satellite shows the Salt River in Arizona. ©2025 Xplore Inc. All rights reserved. Bellevue, Wash.-based Xplore has released the first hyperspectral images from its XCUBE-1 satellite, six months after the shoebox-sized spacecraft was sent into orbit. The pictures, captured with a resolution of 5 meters (16 feet) per pixel, show a river in Arizona, rugged terrain in Saudi Arabia, farmland in Uzbekistan and a settlement in Inner Mongolia — with each image color-coded to reflect wavelengths that go beyond what the eye can see. Such images can be used to assess agricultural crop health, moisture levels and other characteristics of a given terrain. Thermal infrared imagery could be used to track the spectral signatures of seagoing vessels or overland shipments as part of a campaign to crack down on illegal trafficking. For military applications, hyperspectral images could point to newly laid minefields or see through camouflage. And for space applications, Xplore's multi-sensor imaging system could be turned to track other satellites 'Xplore is focused on providing high-quality data products for our customers and partners,' Jeff Rich, co-founder and CEO of Xplore, said today in a news release. 'Our imagery is outperforming expectations, and its exceptional quality stems from the sophisticated ground calibration of our instruments and data processing pipeline. We expect demand for high-quality hyperspectral imagery to expand rapidly in multiple domains.' Two years ago, Xplore won a study contract from the National Reconnaissance Office to look into potential applications for hyperspectral imaging. Last December, XCUBE-1 was launched into low Earth orbit on a SpaceX Falcon 9 rocket as part of the Bandwagon-2 satellite rideshare mission. Xplore says it's been sharing its initial data and exploring use cases with key customers and partners. The company plans to send future satellite platforms into Earth orbit and to other destinations to execute on its 'Space as a Service' business model. 'We're thrilled with Xplore's progress and are thankful for our talented team and partners,' Xplore co-founder and chief operating officer Lisa Rich said. 'Their hard work and dedication are clearly reflected in the outstanding imagery we're producing. We now invite customers to request data samples to assess our data for their programs and projects. The use of these data products will be crucial to produce insights, perform change detection and identify anomalies that are critical to our customers' applications.'
